June 21, 2011
New York, NY-Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to add a new report to its collection of market research and technology assessments publications:
“Tumor Markers: US, Europe, Japan” is a seven-country study designed to assist diagnostics industry executives in evaluating emerging opportunities and developing effective business responses.
Report Highlights
– Sales and market shares of major suppliers by test and country.
– Ten-years test volume and sales forecasts by country and market segment.
– Market dynamics, structure, size, growth and major suppliers
by country.
– Analysis of over 200 current and emerging tumor markers.
– Feature comparison of major tumor marker testing analyzers.
– Assessment of emerging technologies and applications.
– Review of competing/complementing technologies.
– Assessments of major suppliers and start-up firms developing innovative
technologies and products.
– New product development opportunities with potentially
significant market appeal during the next ten years.
“Tumor Markers: US, Europe, Japan” is based on a combination of primary and secondary information sources, including interviews with laboratory directors, as well as executives of leading diagnostics companies and start-up firms developing innovative technologies and product in the U.S., five major European countries and Japan.
Please review Table of Contents and let me know if you have any questions concerning this informative, comprehensive and insightful market research and technology assessment report.
Best regards,
Audrey Baker
Healthcare Research
+1 212 564 2838
